OBSRT Stock Overview
Engages in developing and commercializing medical technology products for patients, healthcare professionals, and hospitals in Norway, Sweden, the United States, and rest of European countries.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Observe Medical ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.0009 |
| 52 Week High | kr0.018 |
| 52 Week Low | kr0.0003 |
| Beta | 0.33 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -91.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| OBSRT | NO Medical Equipment | NO Market | |
|---|---|---|---|
| 7D | 0% | -0.5% | 1.0% |
| 1Y | n/a | 6.8% | 7.5% |
Return vs Industry: Insufficient data to determine how OBSRT performed against the Norwegian Medical Equipment industry.
Return vs Market: Insufficient data to determine how OBSRT performed against the Norwegian Market.
Price Volatility
| OBSRT volatility | |
|---|---|
| OBSRT Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in NO Market | 11.3% |
| 10% least volatile stocks in NO Market | 2.9% |
Stable Share Price: OBSRT's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine OBSRT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 17 | Rune Nystad | observemedical.com |
Observe Medical ASA engages in developing and commercializing medical technology products for patients, healthcare professionals, and hospitals in Norway, Sweden, the United States, and rest of European countries. It offers Sippi, a digital and automated urine measurement system for urine monitoring and biofilm control; and Biim, a wireless pocketable ultrasound device for display of the ultrasound image and video for nurses and medical staff. The company also offers Unometer, Safeti Plus, Unometer 500, UnoMeter, and AbdoPressure products used for drainage, collection, and measurement of urine output from patients, as well as provides medtech devices and disposables within urine measurement, anesthesiology/ICUs, and wound care products.
Observe Medical ASA Fundamentals Summary
| OBSRT fundamental statistics | |
|---|---|
| Market cap | kr15.49m |
| Earnings (TTM) | -kr68.82m |
| Revenue (TTM) | kr19.33m |
0.8x
P/S Ratio-0.2x
P/E RatioIs OBSRT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OBSRT income statement (TTM) | |
|---|---|
| Revenue | kr19.33m |
| Cost of Revenue | kr14.65m |
| Gross Profit | kr4.69m |
| Other Expenses | kr73.51m |
| Earnings | -kr68.82m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Feb 29, 2024
| Earnings per share (EPS) | -1.29 |
| Gross Margin | 24.24% |
| Net Profit Margin | -356.02% |
| Debt/Equity Ratio | 52.8% |
How did OBSRT perform over the long term?
See historical performance and comparison